• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156

Recent Advances in the Study of 3,6-Dimethyl-1-benzofuran-2-carboxylic Acid (CAS: 16820-37-4)

3,6-Dimethyl-1-benzofuran-2-carboxylic Acid (CAS: 16820-37-4) is a benzofuran derivative that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug development. Benzofuran-based compounds are known for their diverse biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, pharmacological properties, and potential therapeutic applications.

Recent studies have highlighted the synthetic pathways for 3,6-Dimethyl-1-benzofuran-2-carboxylic Acid, with a particular emphasis on green chemistry approaches. Researchers have developed efficient methods for its synthesis using catalytic processes that minimize environmental impact. For instance, a 2023 study demonstrated the use of palladium-catalyzed cross-coupling reactions to achieve high yields of the compound under mild conditions. These advancements are critical for scaling up production while adhering to sustainable practices.

Pharmacological investigations have revealed that 3,6-Dimethyl-1-benzofuran-2-carboxylic Acid exhibits promising activity against various cancer cell lines. In vitro studies have shown that the compound induces apoptosis in breast cancer cells (MCF-7) by modulating the expression of pro-apoptotic proteins such as Bax and caspase-3. Additionally, its anti-inflammatory properties have been explored in models of rheumatoid arthritis, where it significantly reduced the production of pro-inflammatory cytokines like TNF-α and IL-6.

The compound's mechanism of action is believed to involve the inhibition of key signaling pathways, including the NF-κB and MAPK pathways. Molecular docking studies suggest that 3,6-Dimethyl-1-benzofuran-2-carboxylic Acid binds to the active sites of these proteins, thereby disrupting their function. These findings provide a solid foundation for further drug development efforts aimed at targeting these pathways in diseases such as cancer and chronic inflammation.

Despite these promising results, challenges remain in the clinical translation of 3,6-Dimethyl-1-benzofuran-2-carboxylic Acid. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through comprehensive preclinical studies. Recent research has begun to explore structural modifications of the compound to enhance its pharmacokinetic properties while retaining its therapeutic efficacy.

In conclusion, 3,6-Dimethyl-1-benzofuran-2-carboxylic Acid represents a promising candidate for further investigation in the field of medicinal chemistry. Its diverse biological activities and relatively straightforward synthesis make it an attractive target for drug development. Future studies should focus on optimizing its pharmacological profile and evaluating its safety and efficacy in vivo. The continued exploration of this compound may lead to the discovery of novel therapeutics for a range of diseases.

• 24673-56-1(3-methyl-1-benzofuran-2-carboxylic acid)
• 16817-24-6(3,7-DIMETHYL-BENZOFURAN-2-CARBOXYLIC ACID)
• 16817-32-6(3,5-Dimethyl-1-benzofuran-2-carboxylic Acid)
• 38281-61-7(3-(hydroxymethyl)-1-benzofuran-2-carboxylic Acid)
• 99246-99-8(5-hydroxy-3-methyl-2-Benzofurancarboxylic acid)
• 878417-05-1(3,6,7-Trimethyl-1-benzofuran-2-carboxylic acid)
• 2076-36-0(3-Methylbenzofuran-2-carboxylic Acid Methyl Ester)
• 131-76-0(Benzofuran-2,3-dicarboxylic acid)
• 32730-10-2(3-Methylnaphtho1,2-bfuran-2-carboxylic Acid)
• 40763-04-0(3,5,6-Trimethyl-benzofuran-2-carboxylic acid)